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Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in December 
2019.1 As I write this, the coronavirus disease 2019 (COVID-19) pandemic is hitting South Africa 
and events are unfolding fast as new measures are taken on a daily basis to contain its spread 
within communities. This article does not attempt to keep up with the latest announcements and 
news, but to share what we know about the virus and its clinical management. The article is 
targeted at primary care providers, general practitioners and family physicians.
It is clear that containing the virus will require an all-of-society response and that the pandemic 
will impact multiple sectors such as health, business, tourism, education, and trade. Our response 
is intended to contain the spread of the virus and slow the growth of the epidemic in order to 
allow the health system to cope. 
There is a risk of stigma for those infected and a plethora of misinformation, panic and anxiety.
Facilities and healthcare practices should adequately prepare themselves to cope with the 
epidemic, and a checklist, along with other resources, has been provided on the National Institute 
of Communicable Diseases (NICD) website at http://www.nicd.ac.za/diseases-a-z-index/
COVID-19/COVID-19-resources/.
Clinical picture




• Difficulty breathing (31%)
• Fatigue and myalgia (11%)
The most common presentation is myalgia, malaise, cough, and a low-grade fever. Difficulty 
breathing may develop in the second week (average 8 days) due to viral pneumonia.
Symptoms such as sore throat, runny nose, headache, chest pain, confusion, diarrhoea, nausea 
and vomiting are also possible, but much less common. Most patients (90%) have more than one 
South Africa is in the grip of a novel coronavirus pandemic (COVID-19). Primary care providers 
are in the frontline. COVID-19 is spread primarily by respiratory droplets contaminating 
surfaces and hands that then transmit the virus to another person’s respiratory system. The 
incubation period is 2–9 days and the majority of cases are mild. The most common symptoms 
are fever, cough and shortness of breath. Older people and those with cardiopulmonary co-
morbidities or immunological deficiency will be more at risk of severe disease. If people meet 
the case definition, the primary care provider should immediately adopt infection prevention 
and control measures. Diagnosis is made by a RT-PCR test using respiratory secretions, 
usually nasopharyngeal and oropharyngeal swabs. Mild cases can be managed at home with 
self-isolation, symptomatic treatment and follow-up if the disease worsens. Contact tracing is 
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symptom, but only 15% have fever, cough and shortness of 
breath together. The cough is most often a dry cough. 
Laboratory findings are not that helpful. The most consistent 
finding is a lymphopaenia, while C-reactive protein is 
unreliable. Abnormalities are seen on X-ray in about 60% of 
patients and bilateral pneumonia is the commonest finding.2 
The most consistent finding is a ground glass appearance due 
to interstitial infiltrates.
It should be emphasised that the majority of people will have 
a mild self-limiting illness (81%), while 14% may be more 
severe with hypoxia and dyspnea. Around 5% may become 
critically ill with respiratory failure, septic shock or multi-
organ dysfunction.4
Co-infection with another virus is uncommon and secondary 
bacterial infection is also less common than with influenza.
Patients should be treated in a separate room, although not 
necessarily an airborne infection isolation room, as measures 
to prevent contact and surface contamination are most 
important. 
Case definition
The current case definition for a suspected case or person 
under investigation is5:
•	 Person with acute respiratory illness (sudden onset of at 
least one of the following: cough, sore throat, shortness of 
breath or fever irrespective of severity)
This in combination with:
• At least one of the following epidemiological criteria in 
the 14 days prior to onset of symptoms:
 ß Was in close contact with a confirmed or probable 
case of SARS-Cov-2 infection.
 ß Had a history of travel to areas with presumed 
ongoing community transmission of SARS-CoV-2.
 ß Worked in, or attended, a healthcare facility where 
patients with SARS-CoV-2 infections were being 
treated.
Anyone admitted with a severe pneumonia of unknown 
aetiology should also be regarded as a possible case.
Diagnosis
The main diagnostic is a real-time reverse transcriptase 
polymerase chain reaction (RT-PCR) test on respiratory 
secretions. Secretions are typically obtained by a 
nasopharyngeal (Box 1) and oropharyngeal swab (Box 2) 
placed in universal transport medium and kept cool 
(between 2 °C – 8 °C). The test can also be performed on 
sputum or tracheal aspirate if available. In hospital, 
bronchoalveolar lavage can also be used to collect a sample. 
Serological testing on acute and convalescent serum samples 
can confirm infection, but is not useful for immediate 
diagnosis.
All cases are notifiable as per the NICD: http://www.nicd.
ac.za/notifiable-medical-conditions/.
Case management
If someone meets the case definition given above then 
infection prevention and control measures should be 
immediately adopted and specimens taken for a diagnosis. 
Mild disease can be managed at home (Box 3) with 
symptomatic treatment and self-isolation (Box 4).
Self-isolation can be ended when the patient’s symptoms 
have improved or resolved and they have two consecutive 
negative RT-PCR tests at least 24–48 hours apart.
If severe or critically ill, take or send them to an emergency or 
resuscitation area, keep waste in a designated area and do 
not share equipment with other patients. Consult a more 
senior doctor.
There is no specific treatment for COVID-19 and treatment is 
supportive.8 Treat fever and myalgia with paracetamol and 
offer oxygen if there is difficulty breathing. 
BOX 1: Collecting a nasopharyngeal swab.6
• Use only nylon or rayon flocked swabs with perforated, flexible plastic shaft. 
Cotton-tipped, calcium alginate swabs or swabs with wooden shafts should not 
be used as residues present in these materials may inhibit PCR assays.
• Gently insert nasopharyngeal flocked swab into the nostril aiming backwards, 
along the floor of the nasal cavity, until the nasopharynx is reached. Be careful 
not to insert swab upwards. If resistance is encountered during insertion of the 
swab, remove it and try the other nostril. The distance from the nose to the ear 
gives an estimate of the distance the swab should be inserted. 
• Gently rotate the swab and hold in place for a few seconds. 
• Slowly withdraw swab. 
• Unscrew and remove the cap from the tube with transport medium. 
• Insert the swab directly into a vial containing universal transport medium 
(UTM). 
• Break plastic shaft at the break point so that it can fit in the UTM tube. 
• Close the tube with the lid. 
• Refrigerate at 2 °C – 8 °C.
Source: National Institute for Communicable Diseases. Guidelines for case-finding, diagnosis, 
management and public health response in South Africa [homepage on the Internet]. 2020 
[cited 2020 Mar 18]. Available from: http://www.nicd.ac.za/wp-content/uploads/2020/02/
Guidelines-for-case-finding-diagnosis-management-and-public-health-response-in-South-
Africa.pdf
PCR, polymerase chain reaction.
BOX 2: Collecting an oropharyngeal swab.6
• Keeping the same pair of gloves on, and holding the universal transport medium 
(UTM) with the nasopharyngeal swab in, take a second flocked swab and open it 
at the plastic shaft. 
• Ask the patient to tilt their head back and open mouth wide. 
• Hold the tongue down with a tongue depressor. 
• Have the patient say ‘aahh’ to elevate the uvula.
• Swab each tonsil first, then the posterior pharynx in a ‘figure 8’ movement.
• Avoid swabbing the soft palate and do not touch the tongue with the swab tip 
as this procedure can induce the gag reflex. 
• Insert the swab directly into the same UTM vial containing the nasopharyngeal 
swab. 
• Break plastic shaft at the break point so that it can fit in the UTM tube. 
• Close the tube with the lid. 
• Refrigerate at 2 °C – 8 °C.
Source: National Institute for Communicable Diseases. Guidelines for case-finding, diagnosis, 
management and public health response in South Africa [homepage on the Internet]. 2020 
[cited 2020 Mar 18]. Available from: http://www.nicd.ac.za/wp-content/uploads/2020/02/
Guidelines-for-case-finding-diagnosis-management-and-public-health-response-in-South-
Africa.pdf
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Differential diagnosis would include other viral pneumonia, 
such as from seasonal influenza, bacterial pneumonia 
(conventional and atypical organisms) and, in the HIV 
immunocompromised population, Pneumocystis jirovecii 
pneumonia.
Critically ill patients may need intubation and ventilation 
and treatment in a high care or intensive care unit.
Contact tracing
Once someone is diagnosed with COVID-19, contact tracing 
must start immediately. Contacts are divided into two 
groups:
•	 Close contacts: A person having had face-to-face contact 
(≤ 2 m) or was in a closed environment with a COVID-19 
case; this includes, amongst others, all persons living in 
the same household as a COVID-19 case, and people 
working closely in the same environment as a case. A 
healthcare worker or other person providing direct care 
for a COVID-19 case, while not wearing recommended 
personal protective equipment (PPE) (e.g. gowns, gloves, 
NIOSH-certified disposable N95 respirator, eye 
protection). A contact in an aircraft sitting within two 
seats (in any direction) of the COVID-19 case, travel 
companions or persons providing care, and crew 
members serving in the section of the aircraft where the 
index case was seated.
•	 Casual contacts: Anyone not meeting the definition for a 
close contact, but with possible exposure.
Close contacts should self-quarantine at home and be 
monitored by daily telephonic follow up for 14 days for the 
development of symptoms. Casual contacts should ensure 
social distancing and avoid non-essential contact and self-
monitor for 14 days. If symptoms develop, they should be 
investigated as already described.
Case fatality rates
Observed case fatality rates may be higher than reality as it is 
difficult to count all of the mild cases making up the 
denominator. Most observations place the overall case fatality 
rate as less than 3% (range 0.5% – 4%) and modelling suggests 
between 0.3% and 1.0%. This is probably more than seasonal 
influenza, on a par with swine flu or measles, and considerably 
less than Spanish flu, severe acute respiratory syndrome 
(SARS) or Middle East respiratory syndrome (MERS).
Figures from China suggest that case fatality increases 
with age from 0.2% in young adults to 3.6% (60–69 years), 8% 
(70–79 years) and 15% (≥ 80 years). In China, the overall 
mortality for males (2.8%) was higher than females (1.7%).4
People with cardiopulmonary co-morbidity (e.g. cardiovascular 
disease, diabetes, structural lung damage, tuberculosis or 
chronic obstructive pulmonary disease) have a higher 
morbidity and mortality. In South Africa we can postulate that 
immunocompromised patients, particularly those with poorly 
controlled HIV, will be at higher risk, as might tobacco smokers. 
Spread of the infection
It is estimated that an infected person on average infects 
between 2 and 4 other people. This is on a par with the 
common cold, and far less than chickenpox or measles. 
Infection is mostly by respiratory droplets contaminating 
surfaces and being passed by hand to one’s own respiratory 
tract. Infection is less common by airborne spread of droplets 
that are breathed in, although some hospital procedures may 
generate an aerosol (e.g. Bilevel Positive Airway Pressure 
machines).
Transmission is most likely when the person is symptomatic. 
Transmission may be possible between asymptomatic people 
in the incubation period, but the extent of this is not known. 
Viral shedding can be detected for 1–4 weeks after symptoms 
resolve, but the extent of infectivity is not known as particles 
detected may not be viable.
BOX 3: Criteria for mild disease in adults and adolescents.7
SpO2 ≥ 95%
Respiratory rate < 25/min
Heart rate < 120/min
Temperature 36 °C – 39 °C
Mental state normal
Source: National Institute for Communicable Disease. Clinical management of suspected or 
confirmed COVID-19 disease [homepage on the Internet]. 2020 [cited 2020 Mar 18]. 
Available from: http://www.nicd.ac.za/wp-content/uploads/2020/03/Clinical_management_ 
of_suspected_or_acute_COVID_V1.1_13.03.20_updated.pdf
BOX 4: Instructions for self-isolation.7
• Patients should stay in a specific room and use their own bathroom (if possible). 
Patients should avoid unnecessary travel and unnecessary contact with other 
people. 
• Where contact is unavoidable, the patient should wear a surgical mask, and 
maintain a distance of at least 1 m (preferably 2 m) from other people. 
• Patients should clean their hands frequently with soap and water. Alcohol-based 
sanitisers may also be used, provided they contain at least 70% alcohol. 
• Patients should practise good cough and sneeze hygiene, by using a tissue, and 
then immediately discarding the tissue in a lined trash can, followed by washing 
hands immediately. 
• Patients should not have visitors in their home. Only those who live in their 
home should be allowed to stay. 
• If they live in shared accommodation (university halls of residence or similar) 
with a communal kitchen, bathroom and living area, they should stay in their 
room with the door closed, only coming out when necessary, wearing a 
face mask if they do so. 
• Patients should avoid sharing household items such as dishes, cups, eating 
utensils and towels. After using any of these, the items should be thoroughly 
washed with soap and hot water. 
• All high-touch surfaces such as table tops, counters, toilets, phones, computers, 
etc. should be cleaned both appropriately and frequently.
• If patients need to wash laundry at home before the results are available, then 
they should wash all laundry at the highest temperature compatible for the 
fabric using laundry detergent. This should be above 60 °C. If possible, they 
should tumble dry and iron using the highest setting compatible with the fabric. 
Disposable gloves and a plastic apron should be used when handling soiled 
materials, if possible, and all surfaces, as well as the area around the washing 
machine, should be cleaned. Laundry should not be taken to a laundrette. The 
patient should wash their hands thoroughly with soap and water after handling 
dirty laundry (remove gloves first if used). 
• Patients should know who to call if they develop any worsening symptoms, so 
that they can safely be reassessed, as 10% – 15% of patients may worsen. Older 
patients (> 50 years) or those with co-morbidities are most likely to worsen.
• Provide a patient information sheet.
Source: National Institute for Communicable Disease. Clinical management of suspected 
or confirmed COVID-19 disease [homepage on the Internet]. 2020 [cited 2020 Mar 18]. 
Available from: http://www.nicd.ac.za/wp-content/uploads/2020/03/Clinical_management_ 
of_suspected_or_acute_COVID_V1.1_13.03.20_updated.pdf
Page 4 of 4 CPD Article
https://www.safpj.co.za Open Access
Infection prevention and control
When handling a suspected or confirmed case you should 
isolate them in a single room or separate them from other 
patients by at least 2 m and put a surgical mask on the patient. 
All staff providing clinical care should wear a surgical mask, 
apron and gloves.
If you are going to perform a procedure that creates an 
aerosol then wear a fit-tested N95 respirator during the 
procedure instead of a surgical mask and eye protection as 
well as the apron and gloves. Such procedures include taking 
nasopharyngeal or oropharyngeal swabs, sputum samples or 
tracheal aspirates. The single room should be adequately 
ventilated. 
Medical equipment, including stethoscope or blood pressure 
cuffs and thermometers should be cleaned and disinfected 
before using on another patient.
In the community, people should avoid infection by:
•	 Regularly washing hands for 20 seconds with soap and 
water or hand sanitiser – particularly after visiting the 
bathroom, before and after eating, after blowing your 
nose, or coughing or sneezing.
•	 Avoiding touching the face or nose with uncleaned hands.
•	 Avoid close contact with sick people, stay at least 2 m 
away from someone that is coughing.
People should avoid spreading the infection:
•	 Social distancing, staying at home and avoiding contact 
with groups of people.
•	 Self-isolation if you are a contact of a case, a person under 
investigation or a confirmed case.
•	 Cough or sneeze into the crook of your elbow or into a 
tissue, which is disposed of immediately in a closed 
container. Wash hands. 
•	 Do not share with other people items such as clothing, 
bedding, towels, cell phones, uncovered food, books and 
magazines.
•	 Close the lid when you flush the toilet.
•	 Wipe frequently touched areas regularly with a disinfectant.
•	 Hand hygiene.
• It is not useful to wear a surgical mask unless you are a 
suspected or confirmed case.
Self-care and team-based care
The COVID-19 epidemic may put even more pressure on 
healthcare workers who already feel overstretched. Doctors 
and nurses who are caring for people with COVID-19 will 
also be anxious about infecting themselves and taking the 
infection home to their families. The epidemic may be with 
us for several months and we will need to pace ourselves. 
Mindful awareness of levels of stress and one’s need to take 
a break is important in order to recharge during the day. We 
are not superhuman and also need to ensure sufficient sleep 
and food to continue working effectively. Self-compassion 
and compassion for those around us in our teams is 
important. Acknowledging and witnessing one another’s 
experiences may help the team to cope with what can feel 
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